Medcaw Investments (MCI) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock MCI vs. MNTC, MFAI, ALGW, D467, CMB, RGO, CCPE, WSL, OTT, and NCAShould you be buying Medcaw Investments stock or one of its competitors? The main competitors of Medcaw Investments include The Schiehallion Fund (MNTC), Mindflair (MFAI), Alpha Growth (ALGW), Thames Ventures VCT 2 DP67 (D467), Cambria Africa (CMB), RiverFort Global Opportunities (RGO), CVC Credit Partners European Opportunities (CCPE), Worldsec (WSL), Oxford Technology 3 Venture Capital Trust (OTT), and New Century AIM VCT (NCA). These companies are all part of the "asset management" industry. Medcaw Investments vs. The Schiehallion Fund Mindflair Alpha Growth Thames Ventures VCT 2 DP67 Cambria Africa RiverFort Global Opportunities CVC Credit Partners European Opportunities Worldsec Oxford Technology 3 Venture Capital Trust New Century AIM VCT The Schiehallion Fund (LON:MNTC) and Medcaw Investments (LON:MCI) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations. Do insiders and institutionals have more ownership in MNTC or MCI? 24.2% of The Schiehallion Fund shares are held by institutional investors. 0.1% of The Schiehallion Fund shares are held by insiders. Comparatively, 27.5% of Medcaw Investments shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in MNTC or MCI? The Schiehallion Fund and Medcaw Investments both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformThe Schiehallion FundN/AN/AMedcaw InvestmentsN/AN/A Which has better valuation and earnings, MNTC or MCI? Medcaw Investments has higher revenue and earnings than The Schiehallion Fund. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Schiehallion Fund-£256.11M0.00-£267.21M£0.09N/AMedcaw InvestmentsN/AN/AN/A-£0.04N/A Is MNTC or MCI more profitable? The Schiehallion Fund's return on equity of -19.31% beat Medcaw Investments' return on equity.Company Net Margins Return on Equity Return on Assets The Schiehallion FundN/A -19.31% -12.03% Medcaw Investments N/A -51.13%-10.82% Does the media prefer MNTC or MCI? In the previous week, The Schiehallion Fund's average media sentiment score of 1.34 beat Medcaw Investments' score of 0.00 indicating that The Schiehallion Fund is being referred to more favorably in the media. Company Overall Sentiment The Schiehallion Fund Positive Medcaw Investments Neutral SummaryThe Schiehallion Fund beats Medcaw Investments on 5 of the 8 factors compared between the two stocks. Get Medcaw Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for MCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCI vs. The Competition Export to ExcelMetricMedcaw InvestmentsAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£775,000.00£1.19B£5.71B£2.87BDividend YieldN/A4.42%4.18%4.96%P/E Ratio-87.5020.8312.74126.70Price / SalesN/A2,412.901,740.71269,141.88Price / CashN/A60.4649.6228.01Price / BookN/A1.151.343.87Net IncomeN/A£263.32M£1.22B£5.88B Medcaw Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCIMedcaw InvestmentsN/AN/AN/AN/A£775,000.00N/A-87.503Gap DownHigh Trading VolumeMNTCThe Schiehallion FundN/AN/AN/AN/A£3.08M£-256,110,000.004.89N/APositive NewsGap DownMFAIMindflairN/AGBX 0.82-3.5%N/AN/A£3.01MN/A-82.003ALGWAlpha GrowthN/AN/AN/AN/A£2.87M£4.16M-1.844D467Thames Ventures VCT 2 DP67N/AN/AN/AN/A£2.69MN/A-1,200.00N/AGap DownCMBCambria AfricaN/AN/AN/AN/A£2.45M£1.41M-3.759RGORiverFort Global OpportunitiesN/AN/AN/AN/A£2.25M£433,482.003.1711,900Gap DownCCPECVC Credit Partners European OpportunitiesN/AN/AN/AN/A£2.13MN/A0.00N/AGap DownWSLWorldsecN/AGBX 2flatN/AN/A£2.13M£-270,215.86-2.65N/AOTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M£-85,000.00-12.59203Gap DownNCANew Century AIM VCTN/AN/AN/AN/A£2.00M£-2,760,000.00-68.92N/A Related Companies and Tools Related Companies The Schiehallion Fund Alternatives Mindflair Alternatives Alpha Growth Alternatives Thames Ventures VCT 2 DP67 Alternatives Cambria Africa Alternatives RiverFort Global Opportunities Alternatives CVC Credit Partners European Opportunities Alternatives Worldsec Alternatives Oxford Technology 3 Venture Capital Trust Alternatives New Century AIM VCT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MCI) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medcaw Investments Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medcaw Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
